Our Swittons device shown below is a smart device for pharma to distribute to physicians to facilitate remote communication, at the press of a button. Of course, in normal circumstances the device augments the rich (and sometimes face-to-face) relationship between the rep and healthcare provider. In pandemic situations, devices such as these can facilitate communication and ensure business continuity, while keeping your sales representatives out of the hot zones of hospitals and physician offices.
During this time of global pandemic impact and protective travel restrictions, we are working to help key healthcare practitioners maintain communication with pharma, especially regarding critical therapeutic areas. This remote communication helps ensure the continuity of business.
“Swittons is working to limit exposure risk to the Coronavirus, or other pandemics, by eliminating unnecessary visits to hospitals and other healthcare facilities,” stated Swittons CEO and Founder Anupam Nandwana. “By automating the pharma to physician relationship, our goal is that professionals working in the field of pharmaceutical sciences will not be forced to risk their own health, and will not become a serious risk factor for the spread of the virus.”
After the 3-month period, which we hope will resolve a pandemic situation, companies that have engaged Swittons can discontinue the platform with no additional charges. However, initial feedback regarding the Swittons program indicates the platform creates tangible value with or without a pandemic issue.